Here, we also found that higher Megf6 transcript levels are associated with poor outcome in this neuroblastoma subset (Fig. 2c), and this is consistent with our RNA-seq data and the delayed tumorigenesis observed in the Th-MYCN/Casp2−/− mouse model30. Here, CASP2 is linked to neuroblastoma.